Professor Michael Sullivan is a Paediatric Oncologist and Neuro-Oncologist in the Children’s Cancer Centre, Royal Children’s Hospital, Melbourne, a Professor of Paediatrics, Department of Paediatrics, University of Melbourne, and an Honorary Professor of Paediatrics, University of Otago, New Zealand. He is Continental President (Oceania) for the International Society of Paediatric Oncology (SIOP)  and the official SIOP liaison to the WHO Global Initiative for Childhood Cancer.  In 2020 he was elected as Co-Chair of SIOP Global Health (formerly Paediatric Oncology in Developing Countries), a network of over 1300 SIOP members in 119 countries.

A graduate of the University of Otago Medical School (NZ) he trained in Paediatrics and Paediatric Oncology in New Zealand and Australia and did his PhD on DNA methylation and Genomic Imprinting in Wilms tumour. He has extensive experience in clinical trials and translational research, in particular hepatoblastoma, Wilms tumour, neuroblastoma and brain tumours.  Professor Sullivan has a long-term commitment to Global Oncology especially in the Pacific, Oceania ans SE Asia. He led the establishment of childhood cancer twinning programs with Fiji, PNG, Timor-Leste and Laos. Professor Sullivan is a core member of the WHO Global Initiative For Childhood Cancer (GICC), a program aimed at improving the overall survival of children with cancer to 60% by 2030. He is now Co-Director of the ARIA Global Guideline Collaboration an initiative between SIOP, St Jude, IPSO, PROS and CCI to develop resource adapted treatment guidelines for children with cancer in Low and Middle Income countries.